References
- Chow SM, Law SC, Chan JK, Au SK, Yau S, Lau WH. Papillary microcarcinoma of the thyroid: Prognostic significance of lymph node metastasis and multifocality. Cancer. 2003;98:31-40. https://doi.org/10.1002/cncr.11442
- Mansour J, Sagiv D, Alon E, Talmi Y. Prognostic value of lymph node ratio in metastatic papillary thyroid carcinoma. J Laryngol Otol. 2018;132:8-13. https://doi.org/10.1017/S0022215117002250
- Hutter RV, Frazell EL, Foote FW Jr. Elective radical neck dissection: An assessment of its use in the management of papillary thyroid cancer. CA Cancer J Clin. 1970;20:87-93.
- Lundgren CI, Hall P, Dickman PW, Zedenius J. Clinically significant prognostic factors for differentiated thyroid carcinoma: A population-based, nested case-control study. Cancer. 2006;106: 524-531. https://doi.org/10.1002/cncr.21653
- Bhattacharyya N. Surgical treatment of cervical nodal metastases in patients with papillary thyroid carcinoma. Arch Otolaryngol Head Neck Surg. 2003;129:1101-1104. https://doi.org/10.1001/archotol.129.10.1101
- Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016;26:1-133. https://doi.org/10.1089/thy.2015.0020
- Jin H, Yan H, Tang H, Zheng M, Wu C, Liu J. Internal Spreading of Papillary Thyroid Carcinoma: A Case Report and Systemic Review. Case Rep Endocrinol. 2018;2018:7618456. https://doi.org/10.1155/2018/7618456
- Pereira F, Pereira SS, Mesquita M, Morais T, Costa MM, Quelhas P, et al. Lymph Node Metastases in Papillary and Medullary Thyroid Carcinoma Are Independent of Intratumoral Lymphatic Vessel Density. Eur Thyroid J. 2017;6:57-64. https://doi.org/10.1159/000457794
- Iacobone M, Jansson S, Barczynski M, Goretzki P. Multifocal papillary thyroid carcinoma: A consensus report of the European Society of Endocrine Surgeons (ESES). Langenbecks Arch Surg. 2014;399:141-154. https://doi.org/10.1007/s00423-013-1145-7
- Kim HJ, Sohn SY, Jang HW, Kim SW, Chung JH. Multifocality, but not bilaterality, is a predictor of disease recurrence/persistence of papillary thyroid carcinoma. World J Surg. 2013;37:376-384. https://doi.org/10.1007/s00268-012-1835-2
- Muzza M. The clonal origin of multifocal papillary thyroid cancer (MPTC): Intrathyroid spread or independent tumors. Minerva Endocrinol. In press; 2020.
- Joseph KR, Edirimanne S, Eslick GD. Multifocality as a prognostic factor in thyroid cancer: A meta-analysis. Int J Surg. 2018;50:121-125. https://doi.org/10.1016/j.ijsu.2017.12.035
- Choi WR, Roh JL, Gong G, Cho KJ, Choi SH, Nam SY, et al. Multifocality of papillary thyroid carcinoma as a risk factor for disease recurrence. Oral Oncol. 2019;94:106-110. https://doi.org/10.1016/j.oraloncology.2019.05.023
- Harries V, Wang LY, McGill M, Xu B, Tuttle RM, Wong RJ, et al. Should multifocality be an indication for completion thyroidectomy in papillary thyroid carcinoma? Surgery. 2020;167:10-17. https://doi.org/10.1016/j.surg.2019.03.031
- Xue S, Wang P, Liu J, Chen G. Total thyroidectomy may be more reasonable as initial surgery in unilateral multifocal papillary thyroid microcarcinoma: A single-center experience. World J Surg Oncol. 2017;15:62. https://doi.org/10.1186/s12957-017-1130-7